Utility of Presepsin and Interferon-λ3 for Predicting Disease Severity and Clinical Outcomes in COVID-19 Patients

We explored the utility of novel biomarkers, presepsin and interferon-λ3 (IFN-λ3), for predicting disease severity and clinical outcomes in hospitalized Coronavirus (COVID-19) patients. In a total of 55 patients (non-critical, n = 16; critical, n = 39), presepsin and IFN-λ3 were compared with sequen...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Gun-Hyuk, Park, Mikyoung, Hur, Mina, Kim, Hanah, Lee, Seungho, Moon, Hee-Won, Yun, Yeo-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377783/
https://www.ncbi.nlm.nih.gov/pubmed/37510116
http://dx.doi.org/10.3390/diagnostics13142372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377783/
https://www.ncbi.nlm.nih.gov/pubmed/37510116
http://dx.doi.org/10.3390/diagnostics13142372

Ejemplares similares